Institute: Dutch Medicines Evaluation Board
Function: Principal Investigator
Education and experience:
Bert obtained his PharmD and PhD degree from Utrecht University. In 1997 he was appointed as full professor in Pharmacoepidemiology at the same university. From 2003-2005 he was the Scientific Director of the Utrecht Institute for Pharmaceutical Sciences; in 2006-2007 the Dean of Pharmaceutical Sciences. Since 2007 he is the Chair of the Dutch Medicines Evaluation Board. Moreover, Dr Leufkens is active at several (inter)national platforms on pharmacoepidemiology and regulatory science (e.g. past-President of ISPE, former member of EMA Pharmacovigilance Working Party, and EMA CHMP). He is (co) author of >400 papers in peer reviewed journals, book chapters and research reports. His key interests relevant for the Centre are pharmaceutical policy analysis, regulatory science, international health, risk assessment, public health, orphan drugs and scenario planning.